Clover Health Investments EBITDA Margin 2020-2025 | CLOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Clover Health Investments (CLOV) over the last 10 years. The current EBITDA margin for Clover Health Investments as of March 31, 2025 is .
| Clover Health Investments EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $1.49B | $-0.02B | -1.62% |
| 2024-12-31 | $1.37B | $-0.05B | -3.36% |
| 2024-09-30 | $1.35B | $-0.09B | -6.54% |
| 2024-06-30 | $1.32B | $-0.11B | -8.55% |
| 2024-03-31 | $1.29B | $-0.15B | -11.36% |
| 2023-12-31 | $1.26B | $-0.21B | -16.35% |
| 2023-09-30 | $-0.53B | $-0.17B | 31.33% |
| 2023-06-30 | $0.02B | $-0.21B | -1150.00% |
| 2023-03-31 | $0.55B | $-0.28B | -51.93% |
| 2022-12-31 | $1.10B | $-0.29B | -26.16% |
| 2022-09-30 | $3.01B | $-0.45B | -14.92% |
| 2022-06-30 | $2.58B | $-0.52B | -20.31% |
| 2022-03-31 | $2.15B | $-0.60B | -28.16% |
| 2021-12-31 | $1.47B | $-0.62B | -42.28% |
| 2021-09-30 | $1.21B | $-0.50B | -41.24% |
| 2021-06-30 | $0.95B | $-0.37B | -38.54% |
| 2021-03-31 | $0.71B | $-0.16B | -21.92% |
| 2020-12-31 | $0.67B | $-0.07B | -10.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.527B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Doximity (DOCS) | United States | $11.561B | 53.52 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Omnicell (OMCL) | United States | $1.291B | 22.78 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.582B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |